Emerald Mutual Fund Advisers Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,530
| Closed | -$148K | – | 233 |
|
|
2023
Q4 | $148K | Buy |
1,530
+582
| +61% | +$56.1K | 0.01% | 226 |
|
|
2023
Q3 | $83.9K | Sell |
948
-21
| -2% | -$1.86K | 0.01% | 226 |
|
|
2023
Q2 | $84K | Buy |
+969
| New | +$84K | ﹤0.01% | 229 |
|
|
2023
Q1 | – | Sell |
-1,049
| Closed | -$109K | – | 221 |
|
|
2022
Q4 | $109K | Buy |
+1,049
| New | +$109K | 0.01% | 198 |
|